Simple Summary
Community health workers can help underserved women overcome barriers to breast and cervical cancer screening, but the resources required and outcomes achieved may differ across communities. This study examined two community–clinical linkage programs in urban and rural Colorado as they transitioned from generalized outreach to individualized assistance. Using a cost–consequence approach, we found that program reach, screening completion, and costs varied over time and between sites, particularly during the COVID-19 pandemic. The findings highlight the importance of considering the populations served, local infrastructure, and barriers to care when evaluating and sustaining community-based cancer screening outreach programs.
Abstract
Background: Community–clinical linkage (CCL) models incorporating community health workers (CHWs) can address barriers to cancer screening among underserved women. We evaluated the costs, outcomes, and implementation experiences of two CCL programs in Colorado, one urban and one rural, transitioning from generalized outreach to individualized assistance for breast and cervical cancer screening. Methods: Using program expenditure and participant data from 2018 to 2021, we conducted a cost–consequence analysis comparing the final year of the Targeted Outreach Program (TOP) with three years of The Community Outreach (TCO) model. Outcomes included program reach, screening completion, screening rates, and average costs per woman receiving assistance and per woman screened. Results: At the urban site, women receiving assistance increased from 204 under TOP to 333 in the first TCO year, while screening completion declined from 69% to 60%. Women screened increased from 140 to 201, and average cost per woman screened declined from $2363 to $1746. By 2021, the screening rate reached 76%, and the proportion of Hispanic women served increased substantially. At the rural site, screening rates increased from 67% in 2019 to 95% in 2020, while average cost per woman screened declined from $2513 to $2370. During the COVID-19 pandemic, the rural screening rate fell to 50%, and average cost per woman screened increased to $4601. Conclusions: CCL program costs and outcomes varied across geographic settings, implementation periods, and populations served. Cost–consequence analysis illustrates the importance of evaluating program reach, screening completion, and costs separately, particularly when outreach targets women facing substantial barriers to care. Organizational infrastructure and the capacity to adapt to disruptions are important considerations for program sustainability and equitable screening access.
1. Introduction
The United States (US) National Institutes of Health (NIH) reports that an estimated 321,910 women will be newly diagnosed with invasive breast cancer, and approximately 42,140 will die from this cancer in 2026 in the US [1]. In addition, around 13,490 new cases of invasive cervical cancer will be diagnosed, and an estimated 4200 women will die from this cancer in 2026 [2]. Increasing screening rates and early detection of these cancers is critical to reducing these numbers. Women in the US still face significant barriers to screening and follow-up care, which include knowledge about cancer risks, logistical issues related to accessing services, and health system mistrust [3,4].
The US Centers for Disease Control and Prevention’s (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP), initiated in 1990, supports programs to increase breast and cervical cancer screening rates among low-income and medically underserved women [5]. In 2018, the NBCCEDP shifted funding from general outreach programs, which varied by location, to those using a Community Clinical Linkage (CCL) model and evidence-based interventions to increase screening among underserved women.
The CDC defines CCL as connections between non-health community sectors, such as social community centers and faith-based organizations, and clinical providers, such as hospitals and rural clinics, to improve population health [6]. Models can take a variety of forms, given the entities forming partnerships and the degree of connection between them. Connections can fall on a continuum from basic information sharing through networking activities to integrated programs and shared resources between partners. CCL approaches have proven effective in preventing cardiovascular disease and managing obesity [7,8].
NBCCEDP funded state grantees who implemented CCL models using evidence-based outreach interventions (EBIs), identified by the United States (US) Community Preventive Services Task Force as effective in increasing breast and cervical screening rates [9]. In this case, the models consisted of partnerships between community organizations involved in non-health outreach, such as food pantries, and clinical providers offering screening services to improve service coordination and eliminate barriers to screening for underserved women [10,11].
As defined by the Task Force, evidence-based outreach includes one-on-one or group education, providing client reminders, and reducing out-of-pocket costs [12]. A recent systematic review of the EBI cost-effectiveness literature found substantial variation in intervention design, components, and resource intensity, with the most common intervention being one-on-one education with CHWs [13].
CHWs can strengthen community–clinical linkages by connecting individuals not routinely engaged in healthcare with clinical providers for screening. As trusted community members, CHWs can help engage individuals who may be hard to reach through traditional healthcare delivery systems because of limited insurance coverage, transportation barriers, language differences, low health literacy, or distrust of healthcare institutions [14]. Community-based breast and cervical cancer screening outreach programs that employ CHWs, have demonstrated effectiveness in increasing screening participation through culturally appropriate education, appointment scheduling, and language translation, particularly among the Hispanic population [15,16].
The EBI systematic review also reported on economic measures and program cost-effectiveness. The authors found an average total program cost per woman screened for breast cancer of $19 (SD = $20.2; 2021 dollars) and an average increase in the screening rate of 6.56 percentage points (pp) (SD = 4.47) for one-on-one education conducted by CHWs [17,18,19,20,21,22,23,24]. Little is known, however, about community cancer screening outreach programs in real-world settings outside randomized controlled trials, which generally last a year or less [13]. This study aims to conduct a cost–consequence analysis, assessing the costs and outcomes of two CCL models of combined breast and cervical cancer screening outreach. The cost–consequence approach supports a multidimensional assessment of interventions and allows for program costs and outcomes to be presented separately, rather than as the aggregation of distinct dimensions of screening into a single effectiveness measure. The approach has been used previously in assessments of outreach programs targeting multiple cancers [25,26]. Cost–consequence results may be particularly relevant to organizations deciding on program implementation and sustainability and informative for CCL models focused on underserved populations, where program value may extend beyond screening completion and cost reductions to include program reach.
We focus on two CCL model programs, one rural and one urban. Both were funded by the Colorado Department of Health and the Environment (CDPHE) through the NBCCEDP for a general outreach program. We analyze program outcomes associated with transitioning from a general outreach model to CCL models with CHW-led outreach linked to clinical providers, as program funding requirements changed. We describe each program’s reach in terms of the number of women receiving direct assistance, the number of women screened, and the cancer screening rate, defined as the number of women screened among those receiving direct assistance. We also calculate the average cost per woman receiving direct CHW assistance, and the average cost per woman screened over time as programs mature and the populations served change.
2. Methods
2.1. Program Description
From 2016 to 2018, CDPHE funded general community outreach through the Targeted Outreach Program (TOP), which promoted breast and cervical cancer screening for hard-to-reach populations. Statewide, thirteen TOP organizations distributed over 31,600 evidence-based mailers, trained 775 community organizations and health clinics, sponsored 492 community events, and offered one-on-one or group education to more than 19,600 women over two years [27]. In total, organizations referred over 12,000 women for services, of which 48% were ultimately screened [28].
In 2019, Colorado transitioned from supporting TOP to a CCL partnership model, known as The Community Outreach (TCO). Although implemented differently at each site, central to the model was reliance on CHWs who conducted outreach at locations convenient to the women they were seeking to serve, such as food pantries and churches. They met with women to provide one-on-one education, to identify barriers to their accessing screening services, such as health literacy, transportation, and lack of insurance, and to offer direct assistance to address them, such as assistance in setting up screening appointments and/or providing transportation vouchers.
2.2. Study Setting
The study selected two sites, one rural and one urban, based on population and geographic diversity, the presence of staff with institutional knowledge of the program, and program longevity. Both sites were supported by clinical providers: the urban site was part of a large health system, and the rural site was located within a federally qualified health center (FQHC). Each site had participated in TOP before transitioning to the TCO CCL model. While each conducted general outreach through community events, both primarily relied on patient navigators who identified women for screening via electronic health records (EHRs), then guided them through any subsequent treatment pathways [28,29]. Under TCO, sites shifted to CHWs, whereby the goal was to identify underserved women or those who were due for screening in the community.
We obtained data from the CDPHE on the TOP and TCO programs for fiscal years (FY) 2018 through 2021. As the fiscal year spans 1 July through 30 June, we note the third TCO year, 2021, coincided with the SARS-CoV-2 (COVID-19) pandemic and discuss costs and outcomes in this context. We used a micro-costing approach to estimate TOP and TCO costs from the perspective of the clinic providing support for the community outreach program. Cost data for TOP were available for the second half of 2018, but not for prior years. We estimated annual TOP costs for 2018 by multiplying the second-half values by two. Biannual TCO cost data were available for 2019 through 2021 for each site.
Based on itemized invoiced expenses submitted to the CDPHE, we grouped expenditures into the following categories: assessment and planning, personnel, outreach and education, office supplies, staff travel, travel vouchers provided to women participants and overhead at the federal indirect cost rate, similar to other studies [13,29]. As the invoice forms varied slightly from year to year, we consulted with CDPHE staff to ensure comparability in classifications over time. Costs for all years were converted to 2021 dollars using the consumer price index to adjust for inflation and facilitate comparisons across time periods [30]. They were not discounted, as they were compared as contemporaneous program costs over time rather than as a stream of future costs and outcomes to guide program investment [31]. We did not include the cost of screening, nor the time cost associated with women receiving direct assistance, given that the perspective was that of the clinic outreach provider.
Each TCO participant completed a Worksheet (see Figure S1) with the CHW, who later documented whether the woman ultimately received a screen. CDPHE provided de-identified Participant Worksheet data in Excel files, including final screening status by cancer type. Some data were unavailable for women served under TOP due to differences in reporting between the programs.
Over the period, 2018 to 2021, we assessed the number of women receiving direct CHW assistance, the number of women among those receiving assistance screened, and the proportion screened. For the TOP period, we defined women receiving direct assistance as those who directly interacted with a community outreach worker, such as through individual or group education. Using program cost data, we calculated average total program costs per woman receiving direct assistance and per woman screened. The average cost per woman screened does not include the cost of the cancer screen and only includes outreach program costs.
As outreach for both breast and cervical cancer occurred simultaneously, program costs could not be separated by cancer type. For the average cost calculations, we defined the number of women screened as the number of women receiving a breast or cervical cancer screen, or both. We provide additional data on the type of screens completed over time separate from program costs.
3. Results
3.1. Urban Site Case Study
The urban CCL site is a large, inner-city hospital system with satellite clinics and a mobile van that enables screenings to be completed at community locations. CHWs focused outreach on minority women, particularly non-white women of Hispanic descent. CHWs primarily partnered with community centers and food pantries to conduct outreach, with over half of the activities occurring at these two locations in fiscal years 2019 and 2020. Other sites included health fairs and homeless shelters (See Table S1). The COVID-19 pandemic significantly impacted outreach modalities, prompting the TCO to resume reviewing EHRs to identify women who had never been screened and those who were five years overdue for screening.
Table 1 presents data on race/ethnicity as self-reported by participants and the insurance status of women who received direct assistance from CHWs. The percentage of Black non-Hispanic women served varied over the three years, ranging from 15% to 21%, while Hispanic women constituted an increasingly larger share, rising from 36% in 2019 to 58% in 2021. The percent of white non-Hispanic women receiving direct assistance fell from 33% to 16% during the pandemic.
Table 1.
Race/Ethnicity and Insurance Status of Women Receiving TCO 1 Direct Assistance by Site and Year.
Initially, under TCO, 24% of women served were privately insured, with the percent declining each year to a low of 6% in 2021. The share of women insured by Medicaid or Medicare rose from 2019 to 2020, then fell in 2021 to 44%, below the 2019 share (58%). The percentage of uninsured women remained steady at roughly 20% through 2019, but more than doubled in 2021 to 50%, the year most affected by COVID-19.
Table 2 presents information on reported barriers to screening and the types of direct CHW assistance provided. Many women reported multiple barriers. In 2019, inadequate housing was the most commonly reported barrier, affecting nearly 40% of women, while financial issues, work requirements, and transportation were reported by 20% to 25% of women. This pattern was similar in 2020. A notable change was the growth in language and health literacy barriers, likely reflecting the increase in Hispanic women being served by this TCO. The share of respondents citing lack of insurance as a barrier increased from ~10% to nearly 30% between 2019 and 2021.
Table 2.
Barriers Reported and TCO Direct Assistance Provided by Site and Year 1,2.
CHWs provided one-on-one education, appointment scheduling assistance, and appointment reminders, and successfully scheduled appointments for over 95% of women. The provision of translation services increased dramatically from 2019 to 2021, as did insurance support, due to the growing proportion of uninsured and Hispanic women served.
Table 3 presents costs by spending category. At the urban site, total annual program costs increased from $330,826 in 2018 under TOP to $350,854 in 2019 and to $398,932 in 2020 under TCO. After these increases, costs fell to $362,986 in 2021, the COVID-19 year, primarily due to reductions in spending on marketing and outreach materials and for a project specialist’s time. Personnel accounted for the largest share of program expenditures throughout the study period, representing approximately 52% of total annual program costs in 2018 and 64% in 2021. Care navigator expenditure constituted the largest individual personnel cost, almost doubling from $83,968 in 2018 to $162,520 in 2021. Marketing and outreach materials also accounted for substantial expenditures but declined during the TCO period, from $57,778 to $31,113 in the final year.
Table 3.
Program Costs by Site, TOP and TCO Programs, and Year 1,2,3,4,5,6.
Table 4 shows the number of women receiving direct assistance from CHWs, the number of completed screens, and screening rates for both cancer types aggregated, where the screening rate is defined as the number of women screened among those receiving direct assistance. Combined with data from Table 3, also shown are the cost per woman receiving direct and the cost per woman screened. Program reach increased from 204 women under TOP to 333 in 2019, reflecting, in part, continued EHR use to identify women already connected to the healthcare system as community outreach was phased in. The number of women screened increased throughout TCO implementation, rising most substantially in the first year of TCO, from 140 women under TOP to 201 women.
Table 4.
Women Receiving Assistance and Cancer Screenings, Percent of Women Screened and Costs Per Woman by TOP and TCO Programs, By Site, By Year 1,2,3.
While both numbers for women receiving direct assistance and cancer screens rose, screening rates initially fell during the transition from TOP to TCO, given that the increase in women receiving direct assistance outpaced the number of women receiving screens. As EHR identification was phased out, 30 fewer women received direct assistance, and screening rates rose by 5 pp. In the COVID-19 Year, screening rates increased to 76% as EHR identification of women resumed amid pandemic restrictions.
The cost per woman receiving direct assistance (combining data from Table 3 and Table 4) decreased from $1622 in 2018 to $1054 in 2019, rose to $1321 in 2020, then dipped slightly to $1310 in 2021. The cost per woman screened declined from $2363 in 2018 under TOP to $1746 in 2019 but rose to $2025 in 2020. In the last year of TCO, these costs fell slightly to $1720. Despite fluctuations in annual program expenditures and participation, the cost per completed screening was lower in each TCO year than during the TOP year.
Table 5 provides data on women’s screening status by cancer type (breast, cervical, or both), along with the number of women not screened. Disaggregated data were not available for TOP. Among women screened during the TCO period, breast cancer screening alone accounted for most of the completed screenings in both sites, although its relative contribution declined over time. In 2019, 182 of 201 women screened (91%) in the urban site received breast cancer screening only, compared with 165 of 197, an 84% share, in 2020; 142 of 211 (67%) in 2021 completed breast cancer screenings in 2021. In contrast, the number of women receiving cervical cancer screening alone in this urban site increased from 12 in 2019 to 39 in 2021. The number receiving both breast and cervical cancer screening also increased, from 7 in 2019 to 30 in 2021. The number of women receiving direct assistance but not screened, decreased markedly (132 to 66) over the TCO period. These findings indicate a shift toward a more diversified distribution of cancer screening services during the TCO implementation period in the urban site.
Table 5.
Number of Women Screened Among Those Receiving Direct Assistance by Type of Cancer Screen during TOP and TCO by Site and Year 1,2,3.
3.2. Rural Site Case Study
The rural site serves residents in three frontier counties in western Colorado, where the population density is 6 or fewer people per square mile. Cervical cancer screenings can be performed on site, but women must generally travel significant distances to obtain mammography services. As an FQHC, the site accepts women with Medicaid and those without insurance; citizenship is generally not checked.
CHWs conducted a third of outreach activities at food banks, a percentage that grew over time. They continued limited media outreach for the first year, resulting in 22.4% of referrals (see Table S1). In TCO year two, 28.2% of women came to the TCO through personal referrals. With the onset of COVID-19, outreach shifted to community centers, and EHR review to identify women for possible screenings.
Over half of the women served at the rural site were white, non-Hispanic, with the percent rising from 52% to 92% in 2020, then falling to ~80% in 2021 (Table 1). The percent of Hispanic women receiving direct assistance varied from ~5% to ~13% across the study years. In contrast, no non-Hispanic Black women were served, reflecting the makeup of the surrounding population, where 0.4% of the population is Black [32].
In the first year of TCO, women insured by Medicaid, privately, or uninsured each constituted 31% of those receiving direct assistance, while the remainder were insured by Medicare (Table 1).
In 2020, the percent of women insured by Medicaid fell, while the percent of uninsured women increased to 41.0%. With the onset of COVID-19, the site resumed use of EHR-based identification of women in need of screening and centralized recruitment of women at community centers. As a result, insurance composition changed: privately insured women made up the largest share of the total population at 38%, followed by women insured by Medicare (22%), and the uninsured rate fell by half.
Rural women reported multiple barriers to accessing services (Table 2). Transportation was reported by 69% in the first year, closely followed by financial concerns at 67%. Over 40% of women reported barriers related to literacy, insurance, and a lack of support. In 2020, reported barriers remained consistent, with the percentage reporting financial challenges rising by 13 pp, likely reflecting the increase in uninsured women. Cultural beliefs (70%) and transportation (92%) became the primary barriers reported during 2021.
The TCO focused on one-on-one education by CHWs, which over 90% of participants received over the three years. Nearly three-quarters of women received assistance with appointment scheduling and reminders in 2019, with the percent rising to 90% and above in year 2. In the first two years, approximately one-fifth of participants received a referral for insurance counseling. Transportation vouchers were provided to 62% of participants in 2019 and 54% in 2020. The nature of CHW assistance changed in 2021 with fewer women, a decline of 15 pp, receiving help with appointment scheduling, while the share of women receiving travel vouchers increased to 92%.
3.3. Program Costs and Outcomes
Table 3 shows that during the transition from TOP to TCO, total program spending decreased by 22% ($125,964 to $97,994), with most of the decrease attributable to reduced hours for a patient navigator who had assisted with EHR-identified outreach during TOP. Total expenditures decreased by 10.5% the following year; however, with personnel reallocations, support for the CHW increased. The patient navigator position was eliminated in 2020 but was reinstated during the COVID-19 pandemic when EHR-identified outreach resumed on a limited basis, with total expenditures rising from $87,681 to $115,025.
As shown in Table 4, following the shift from broad-based outreach to TCO, the number of women receiving assistance declined precipitously, from 94 under TOP to 58 in the first year of TCO. This decline likely reflects staffing changes, including the loss of the patient navigator in the first year and reduced spending on a care navigator as the program redirected efforts toward community outreach. The decline continued the following year, potentially as a function of connecting with ’hard-to-reach’ women in a rural area. Numbers rebounded, to a degree, from 39 to 50, under COVID-19 as the site returned to EHR identification of women for outreach and concentrated efforts at a community center.
The proportion of women receiving assistance who completed screening was 66% in 2018 and 67% in 2019, but rose substantially to 95% in 2020, partly reflecting the decline in the number of women receiving direct assistance. In the last year of TCO, during COVID-19, this percentage fell markedly to only 50% in 2021.
The cost per woman receiving direct assistance increased at the rural site from TOP to TCO. These costs were $1340 in 2018, rose to $1690 in 2019, to $2248 in 2020, and to $2300 in 2021. Similarly, the cost per woman screened rose from $2032 in 2018 during TOP to $2513 in 2019. Thereafter, costs fell modestly to $2370 in 2020, then rose substantially to $4601 in 2021. The increase in cost per woman with a completed screen in 2021 coincided with fewer women screened, even though total program expenditures remained below the 2018 TOP level (Table 3).
4. Discussion
This study examined the implementation, costs, and screening outcomes of two CCL programs, one urban and one rural, that transitioned from generalized cancer screening outreach to a model emphasizing individualized CHW assistance for underserved women. Using a cost–consequence approach, we described changes in program reach, screening completion, screening rates, and average program costs over four years. The findings show considerable variation in costs and outcomes across, and within sites. These trends are based on unadjusted descriptive statistics and should not be viewed as solely attributable to TCO; no causal link is suggested here. Factors such as organizational resources, site-specific outreach strategies, the populations served, the barriers they faced, and unmeasured external factors are also important to consider.
4.1. Program Reach, Screening Outcomes, and Costs
The transition from TOP to TCO was a fundamental change in outreach strategy and affected sites differently. At the urban site, the number of women receiving direct assistance increased from 204 under TOP to 333 during the first year of TCO; the screening rate declined from 69% to 60%, while the number of women completing screening increased from 140 to 201. Average cost per woman screened declined from $2363 to $1746. This pattern shows that a reduction in the screening rate did not correspond to a reduction in the total number of women screened nor an increase in the average resources required per completed screening. This finding underscores the importance of considering multiple outcomes when evaluating the “real world” implementation of community-based outreach programs.
The rural site exhibited a different pattern. The number of women receiving direct assistance declined from 94 under TOP to 58 in the first year of TCO, while the screening rate remained relatively stable at approximately 66–67%. The average cost per woman screened increased from $2032 to $2513. These results suggest that transitioning to individualized community outreach may require substantial resources even when fewer women are reached, if geographical dispersion and transportation requirements are substantial and healthcare infrastructure limited.
By the second year of TCO implementation, screening rates improved at both sites, reaching 65% at the urban site and 95% at the rural site. Other studies focused on underserved women have found CHW outreach can increase cancer screening rates [13]. For example, breast cancer screening rates increased by 13 pp among Latinas in El Paso who received direct assistance from a health worker compared to controls [33].
At the urban site, the average cost per woman screened increased to $2025, while at the rural site it declined to $2370. These findings suggest that improvements in screening completion do not necessarily translate into proportional reductions in average costs, particularly when program expenditures and the number of women served also change. They also highlight the importance of considering the stage of program implementation when interpreting economic outcomes.
4.2. Reaching Underserved Populations and Equity Considerations
An important objective of TCO was to increase screening access among underserved women. Program performance should be interpreted in relation to the populations served and the intensity of assistance required to reduce structural barriers within this group and achieve program equity objectives. At the urban site, the percent of Hispanic women receiving direct assistance increased from 36% in 2019 to 58% in 2021, as did the percentage of uninsured women. In response, the program expanded translation and insurance assistance.
The rural site also made successful inroads in serving the uninsured population. However, transportation was a critical barrier. Unlike cervical cancer screening, which could be provided at the rural clinical site, mammography generally required women to travel considerable distances. Transportation vouchers and appointment assistance were therefore important components of this outreach program.
These findings underscore that outreach resources depend not only on the number of women contacted but also on their socioeconomic circumstances and the barriers they face. They also have implications for the economic evaluation of programs serving underserved populations. A higher average cost per woman screened does not necessarily indicate poor program performance when the intervention is designed to reach individuals who would otherwise be unlikely to receive preventive services. Economic assessments should therefore consider differences in the populations served and the resources required to overcome barriers to screening.
4.3. Organizational Capacity and Adaptation to External Disruptions
External factors also influenced the patterns observed. Although both sites experienced pandemic-related restrictions, their responses and screening outcomes differed substantially. The urban site was part of a large health system with established clinical infrastructure, EHR capabilities, satellite clinics, and a mobile screening van. During the pandemic, the program resumed EHR-based identification of women who had never been screened or were substantially overdue for screening. The number of women receiving direct assistance declined modestly, but the screening rate increased to 76%, and the average cost per woman screened declined to $1720. In contrast, the rural site experienced a marked deterioration in screening outcomes. Although the number of women receiving direct assistance increased from 39 to 50 between 2020 and 2021, the number completing screening declined from 37 to 25, and the screening rate fell from 95% to 50%. Even though the site resumed EHR identification and centralized recruitment at community centers, limited access to mammography services, and transportation barriers may have compounded the effects of pandemic-related restrictions.
These contrasting experiences suggest that organizational infrastructure and adaptive capacity are important determinants of program performance and sustainability. Investments in CHW staffing alone may be insufficient without corresponding support for referral systems, transportation, clinical service availability, and mechanisms to maintain contact with participants. Rural CCL programs may require additional infrastructure and more flexible implementation strategies to address geographic barriers and maintain screening access during disruptions.
4.4. Implications for Economic Evaluation and Program Implementation
The findings demonstrate the value of using a cost–consequence framework to evaluate community-based cancer screening outreach. CCL programs produce multiple outcomes, including the number of women reached, the number receiving direct assistance, screening completion, and changes in access among underserved populations. These outcomes provide different perspectives on program performance and may not move in the same direction over time. Presenting them separately allows program administrators and policymakers to assess the resources required to achieve different program objectives without reducing performance to a single economic summary measure. The findings also suggest that economic outcomes should be assessed over sufficient periods to capture program development and changes in the populations served.
5. Limitations
Several limitations should be considered when interpreting these findings. Sample sizes were small, particularly in the rural area. Because this was an observational evaluation without a concurrent comparison group, we stress that changes in screening outcomes cannot be attributed solely to the transition from TOP to TCO. In addition, changes in outreach strategies and the characteristics of women served complicate comparisons across years.
The analysis also relied on program expenditures reported through invoices submitted to the Colorado Department of Public Health and Environment. Although these records provided detailed expenditure information, they may not have captured all resources used to support program implementation. We based overhead expenses on the federal indirect rate included in the NBCCEDP grant supporting the project to account for shared institutional resources. However, we do not know whether the rate reflects actual program-attributable costs. While the costs accounted for here align with those of other studies on breast and cervical cancer outreach, we present them as estimates of program costs, which may over- or understate, to a degree, the full economic resources required to operate the outreach programs [13,34].
The analysis was conducted from the perspective of the clinical organizations providing outreach and did not include the costs of clinical screening services or costs incurred by participants. Data from a systematic review found eight of eleven studies reported participant minutes spent in the intervention, 14.7 min (SD = 8.07) [13]. Four of these translated minutes into dollars, based on the average hourly wage in the area and explicitly included participant costs [20,23,35,36]. Of the studies assessing one-on-one education and client reminders, average participant minutes were 21.2 (SD = 8.55) minutes [19,21,22]. Based on the average hourly minimum wage at the urban and rural sites, we estimate participant costs to be $5.2 and $4.3, respectively, an arguably small amount [37,38]. However, this does not include transportation time to be screened or time spent for screening, which may have affected screening rates especially in the rural site.
Historical data for TOP were limited. We estimated program expenditures for 2018 by annualizing costs reported for the second half of the year. As this was the final year of TOP, we hypothesized that program expenditures were relatively stable. To explore this assumption, we compared expenditure variation across the two six-month reporting periods during the second year of TCO. We found that expenditures varied by 4% between periods at the urban site and by 1.8% at the rural site. These findings suggest that expenditures are unlikely to fluctuate substantially over the biannual invoicing periods once a program has reached a steady state.
Program costs could not be allocated separately to breast and cervical cancer screening because outreach addressed both services simultaneously. This integrated approach reflects a goal of achieving outreach efficiencies given the challenge of reaching underserved women [39]. However, it limits the ability to assess differences in resource requirements and outcomes by cancer type.
We also could not determine the number of women who attended an office visit with a physician and may not have actually been ‘due’ for either the breast or cervical cancer screen. While the outreach personnel did assess their need for a screen based on current guidelines, self-reporting by the woman on the date of their past mammography or cervical cancer screen may not have been fully accurate. We were unable to account for this situation, which may have affected observed screening rates.
We also acknowledge that the study reflects breast and cervical cancer screening guidelines and methods in place at the time. In 2025, guidelines were released related to self-sampling for primary HPV testing [40]. Self-testing eliminates potential barriers to screening, such as transportation, and may lead to increased screening rates among underserved women.
Finally, the study included only two CCL programs in Colorado, selected in part for their geographic diversity, program longevity, and availability of institutional knowledge. Their experiences may not be representative of other programs or geographic settings. We did not conduct sensitivity analyses around the data reported here, as we had no basis for establishing value ranges. We also lacked measures of the strength and quality of community–clinical partnerships and could not determine why some women who received assistance did not complete screening. In addition, the analysis did not assess longer-term outcomes, including diagnostic follow-up, cancer detection, or subsequent health outcomes. These limitations restrict conclusions about the broader clinical and economic benefits of the programs.
6. Conclusions
CCL models that incorporate CHWs offer an important approach to addressing barriers to breast and cervical cancer screening among underserved women. This study shows that program costs and outcomes vary considerably across geographic settings and implementation stages, reflecting differences in reach, participant needs, organizational infrastructure, and external conditions. By presenting program costs and screening outcomes separately, the cost–consequence analysis provides a more comprehensive characterization of program performance. The findings underscore the importance of interpreting program expenditures in relation to the populations served and the barriers that outreach programs seek to overcome. Sustained investment in community partnerships, CHW capacity, and clinical infrastructure may be necessary to ensure access to screening, particularly in rural and other resource-constrained settings. Future evaluations should examine longer-term outcomes, cost differences across screening services, and the potential efficiencies of integrated outreach for multiple cancers. Such evidence can support more informed funding and implementation decisions to improve equitable access to cancer screening.
Supplementary Materials
The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/cancers18223683/s1. Figure S1: Participant Worksheet: The Community Outreach Strategy. Table S1: Outreach Locations by Site and Fiscal Year.
Author Contributions
V.P. and E.K.A. designed the study, conducted and interpreted the analyses, and wrote the manuscript. J.N.H. collected study data, performed analyses, and created statistical tables. All authors have read and agreed to the published version of the manuscript.
Funding
Financial support was provided by the US Centers for Disease Control and Prevention (CDC) under SIP 19-006. Evaluating Community Clinical Linkage Interventions in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
Institutional Review Board Statement
Data for the analysis were provided in de-identified form. The study was reviewed by the Emory Institutional Review Board and was deemed exempt.
Informed Consent Statement
Not applicable.
Data Availability Statement
Data are available upon reasonable request to the first author.
Acknowledgments
The authors would like to acknowledge the contributions of the Colorado Department of Public Health and the Environment staff, Ivy Hontz, Women’s Wellness Connection, and Shannon Lawrence, Chronic Disease and Epidemiology Evaluation Program.
Conflicts of Interest
The authors declare no conflicts of interest.
References
- National Institutes of Health (NIH). National Cancer Institute, Surveillance, Epidemiology and End Results Program. Cancer Stats Facts: Female Breast Cancer. Available online: https://seer.cancer.gov/statfacts/html/breast.html (accessed on 4 August 2026).
- National Institutes of Health (NIH). National Cancer Institute, Surveillance, Epidemiology and End Results Program. Cancer Stats Facts: Cervical Cancer. Available online: https://seer.cancer.gov/statfacts/html/cervix.html (accessed on 4 August 2026).
- Miller, B.C.; Bowers, J.M.; Payne, J.B.; Moyer, A. Barriers to mammography screening among racial and ethnic minority women. Soc. Sci. Med. 2019, 239, 112494. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Akinlotan, M.; Bolin, J.N.; Helduser, J.; Ojinnaka, C.; Lichorad, A.; McClellan, D. Cervical Cancer Screening Barriers and Risk Factor Knowledge Among Uninsured Women. J. Community Health 2017, 42, 770–778. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection and Prevention Program (NBCCEDP). 2024. Available online: https://www.cdc.gov/breast-cervical-cancer-screening/about/?CDC_AAref_Val=https://www.cdc.gov/cancer/nbccedp/about.htm (accessed on 12 September 2024).
- Centers for Disease Control and Prevention. Community-Clinical Linkages for the Prevention and Control of Chronic Diseases: A Practitioner’s Guide; Centers for Disease Control and Prevention, U.S. Department of Health and Human Services: Atlanta, GA, USA, 2016.
- Jilcott, S.B.; Keyserling, T.C.; Samuel-Hodge, C.D.; Rosamond, W.; Garcia, B.; Will, J.C.; Farris, R.P.; Ammerman, A.S. Linking care to community resources for cardiovascular disease prevention: The North Carolina Enhanced WISEWOMAN Project. J. Womens Health 2006, 15, 569–583. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Agency for Healthcare Research and Quality. Integrating Primary Care Practices and Community-Based Resources to Manage Obesity Website. Available online: http://www.ahrq.gov/professionals/prevention-chronic-care/improve/community/obesity-pcpresources/obpcp1.html (accessed on 28 June 2016).
- The Community Guide. CPSTF Findings for Cancer Prevention and Control. 2024. Available online: https://thecommunityguide.cdc.gov/topics/cancer.html (accessed on 27 August 2024).
- Wong, F.L.; Miller, J.W. Centers for Disease Control and Prevention’s National Breast and Cervical Cancer Early Detection Program: Increasing Access to Screening. J. Womens Health 2019, 28, 427–431. [Google Scholar] [CrossRef] [Scilit] [PubMed] [PubMed Central]
- Agency for Healthcare Research and Quality. Clinical Community Relationship Evaluation Roadmap. 2023. Available online: https://www.ahrq.gov/prevention/resources/chronic-care/clinical-community-relationships-eval-roadmap/index.html (accessed on 23 May 2023).
- Levano, W.; Miller, J.W.; Leonard, B.; Bellick, L.; Crane, B.E.; Kennedy, S.K.; Haslage, N.M.; Hammond, W.; Tharpe, F.S. Public education and targeted outreach to underserved women through the National Breast and Cervical Cancer Early Detection Program. Cancer 2014, 120, 2591–2596. [Google Scholar] [CrossRef] [Scilit] [PubMed] [PubMed Central]
- Phillips, V.; Franco Montoya, D.; Adams, E.K. Evaluation of the Cost-Effectiveness of Evidence-Based Interventions to Increase Female Breast and Cervical Cancer Screens: A Systematic Review. Cancers 2024, 16, 1134. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kim, K.; Choi, J.S.; Choi, E.; Nieman, C.L.; Joo, J.H.; Lin, F.R.; Gitlin, L.N.; Han, H.-R. Effects of community-based health worker interventions to improve chronic disease management and care among vulnerable populations: A systematic review. Am. J. Public Health 2016, 106, e3–e28. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Chattopadhyay, S.K.; Pillai, A.; Reynolds, J.; Jacob, V.; Ekwueme, D.; Peng, Y.; Cuellar, A.E. Community Preventive Services Task Force (CPSTF). Breast and Cervical Cancer Screenings: A Systematic Economic Review of Patient Navigation Services. Am. J. Prev. Med. 2024, 67, 618–626. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Fernández, M.E.; Gonzales, A.; Tortolero-Luna, G.; Williams, J.; Saavedra-Embesi, M.; Chan, W.; Vernon, S.W. Effectiveness of Cultivando la Salud: A Breast and Cervical Cancer Screening Promotion Program for Low-Income Hispanic Women. Am. J. Public Health 2009, 99, 936–943. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Vernon, S.W.; McQueen, A.; Tiro, J.A.; del Junco, D.J. Interventions to promote repeat breast cancer screening with mammography: A systematic review and meta-analysis. JNCI J. Natl. Cancer Inst. 2010, 102, 1023–1039. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Costanza, M.E.; Stoddard, A.M.; Luckmann, R.; White, M.J.; Spitz Avrunin, J.; Clemow, L. Promoting mammography: Results of a randomized trial of telephone counseling and a medical practice intervention. Am. J. Prev. Med. 2000, 19, 39–46. [Google Scholar] [PubMed]
- Crane, L.A.; Leakey, T.A.; Ehrsam, G.; Rimer, B.K.; Warnecke, R.B. Effectiveness and cost-effectiveness of multiple outcalls to promote mammography among low-income women. Cancer Epidemiol. Prev. Biomark. 2000, 9, 923–931. [Google Scholar]
- Lairson, D.R.; Chan, W.; Chang, Y.C.; del Junco, D.J.; Vernon, S.W. Cost-effectiveness of targeted versus tailored interventions to promote mammography screening among women military veterans in the United States. Eval. Program Plan. 2011, 34, 97–104. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Saywell, R.M., Jr.; Champion, V.L.; Skinner, C.S.; McQuillen, D.; Martin, D.; Maraj, M. Cost–Effectiveness Comparison of Five Interventions to Increase Mammography Screening. Prev. Med. 1999, 29, 374–382. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Saywell, R.M., Jr.; Champion, V.L.; Skinner, C.S.; Menon, U.; Daggy, J. A cost-effectiveness comparison of three tailored interventions to increase mammography screening. J. Women’s Health 2004, 13, 909–918. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Andersen, M.R.; Hager, M.; Su, C.; Urban, N. Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities. Health Educ. Behav. 2002, 29, 755–770. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Stockdale, S.E.; Keeler, E.; Duan, N.; Derose, K.P.; Fox, S.A. Costs and cost-effectiveness of a church-based intervention to promote mammography screening. Health Serv. Res. 2000, 35, 1037–1057. [Google Scholar] [PubMed] [PubMed Central]
- Haddix, A.C.; Teutsch, S.M.; Corso, P.S. (Eds.) Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation, 2nd ed.; Oxford University Press: Oxford, UK, 2002. [Google Scholar]
- Bensink, M.E. Patient Navigation Research Program. Costs and outcomes evaluation of patient navigation after abnormal cancer screening: Evidence from the Patient Navigation Research Program. Cancer 2014, 120, 570–578. [Google Scholar] [CrossRef] [Scilit] [PubMed] [PubMed Central]
- Colorado Department of Public Health and Environment. Targeted Outreach Program: Outcomes & Activities, Jun 2015–June 2017, Women’s Wellness Connection (CO BCCEDP); Colorado Department of Public Health and Environment: Denver, CO, USA, 2018.
- Patient Navigation & Community Health Worker Training. Community Health Workers and Patient Navigators. 2024. Available online: https://patientnavigatortraining.org/ (accessed on 1 August 2026).
- Allaire, B.T.; Ekweme, D.; Hoerger, T.J.; DeGroff, A.; Rim, S.H.; Subramanian, S.; Miller, J.W. Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program. Cancer Causes Control 2019, 30, 923–929. [Google Scholar] [CrossRef] [Scilit] [PubMed] [PubMed Central]
- US Bureau of Labor Statistics. Consumer Price Index. Available online: https://www.bls.gov/cpi/ (accessed on 15 October 2026).
- Gray, A.M.; Clarke, P.M.; Wolstenholme, J.L.; Wordsworth, S. Applied Methods of Cost-Effectiveness in Health Care (Handbooks in Health Economic Evaluation), 1st ed.; Oxford University Press: Oxford, UK, 2010. [Google Scholar]
- Census Bureau, US. 2020 Census, Summary File 1, Table p2, Country Rurality Level. 2021. Available online: https://www.census.gov/programs-surveys/acs/data/summary-file.html (accessed on 10 October 2026).
- Savas, L.S.; Atkinson, J.S.; Figueroa-Solis, E.; Valdes, A.; Morales, P.; Castle, P.E.; Fernández, M.E. A lay health worker intervention to improve breast and cervical cancer screening among Latinas in El Paso, Texas: A randomized control trial. Prev. Med. 2021, 145, 106446. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ekwueme, D.U.; Gardner, J.G.; Subramanian, S.; Tangka, F.K.; Bapat, B.; Richardson, L.C. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: Selected states, 2003 to 2004. Cancer 2008, 112, 626–635. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Thompson, B.; Thompson, L.A.; Andersen, M.R.; Hager, S.; Taylor, V.; Urban, N. Costs and cost-effectiveness of a clinical intervention to increase mammography utilization in an inner-city public health hospital. Prev. Med. 2002, 35, 87–96. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Chirikos, T.N.; Christman, L.K.; Hunter, S.; Roetzheim, R.G. Cost-effectiveness of an intervention to increase cancer screening in primary care settings. Prev. Med. 2004, 39, 230–238. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- City of Denver Website. 2021 Wages Report. Available online: https://denvergov.org/Government/Agencies-Departments-Offices/Agencies-Departments-Offices-Directory/Auditors-Office/Denver-Labor/2021-Wages-Report (accessed on 10 October 2026).
- First HR Application. Colorado Minimum Wage: State and Local Rates. Available online: https://firsthr.app/compliance-hub/colorado/colorado-minimum-wage (accessed on 10 October 2026).
- Tangka, F.K.L.; Subramanian, S.; Hoover, S.; Cariou, C.; Creighton, B.; Hobbs, L.; Marzano, A.; Marcotte, A.; Norton, D.D.; Kelly-Flis, P.; et al. Improving the efficiency of integrated cancer screening delivery across multiple cancers: Case studies from Idaho, Rhode Island, and Nebraska. Implement Sci. Commun. 2022, 3, 133. [Google Scholar] [CrossRef] [Scilit] [PubMed] [PubMed Central]
- Wentzensen, N.; Massad, L.S.; Clarke, M.A.; Garcia, F.; Smith, R.; Murphy, J.; Guido, R.; Reyes, A.; Phillips, S.; Berman, N.; et al. Self-Collected Vaginal Specimens for HPV Testing: Recommendations From the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee. J. Low. Genit. Tract Dis. 2025, 29, 144–152. [Google Scholar] [CrossRef] [Scilit] [PubMed] [PubMed Central]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.